Xenetic Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €2.16M -1.6% -€3.42M -4.2% -158.4% +0.044 pp -€2.43M -31.5% -112.7% +0.49 pp
    €2.19M +48.8% -€3.57M -35.3% -162.8% +2.1 pp -€3.55M -0.8% -162.0% +0.81 pp
    €1.47M +47.1% -€5.51M +15.2% -374.2% +1.0 pp -€3.58M -12.5% -242.9% +1.7 pp
    €1.00M +165.6% -€4.78M -49.1% -477.7% +20 pp -€4.09M +11.0% -408.2% +5.7 pp
    €376.90K +2,460.3% -€9.40M -31.7% -2,493.1% +910 pp -€3.68M -33.3% -976.6% +370 pp
    €14.72K +∞% -€13.76M +118.5% -93,460.2% -930 pp -€5.52M -1.0% -37,498.0% -370 pp
    €0.00 -100.0% -€6.30M +103.1% N/A -€5.58M -529.9% N/A
    €6.54M +152.8% -€3.10M -93.4% -47.4% +18 pp €1.30M -117.1% 19.8% +3.1 pp
    €2.59M +∞% -€46.76M +333.4% -1,806.9% -18 pp -€7.57M +65.5% -292.3% -2.9 pp
    €0.00 +NaN% -€10.79M -12.6% N/A -€4.57M -56.8% N/A
    €0.00 -100.0% -€12.34M +66.8% N/A -€10.59M +105.4% N/A
    €862.59K +240.6% -€7.40M +35.6% -857.9% +13 pp -€5.15M -2.6% -597.3% +15 pp
    €253.26K -€5.46M -2,155.4% -€5.29M -2,088.5%

    Notifications